Tetrahydropyrimidine Ionizable Lipids for Efficient mRNA Delivery
ACS Nano · 22.10.2024 · 18 (42) · 29045-29058
DOI: 10.1021/acsnano.4c10154 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 11.10.2024. Verfasst von Ivan Isaac und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of Nevada, Las Vegas, Las Vegas, Nevada 89154, United States. Hauptthemen laut MEDLINE: RNA, Messenger, Lipids, Pyrimidines. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIGMS NIH HHS, University of Nevada, Las Vegas.
Abstract (Originalsprache)
Lipid nanoparticles (LNPs) have emerged as an effective and promising technology for messenger RNA (mRNA) delivery, offering a potential solution to physiological barriers and providing an alternative approach to gene therapy without the drawbacks associated with viral delivery. However, efficiently delivering mRNA remains a significant challenge in nucleic acid-based therapies due to the limitations of current LNP platforms in achieving optimal endosomal escape and mRNA release, which largely relies on finding a suitable ionizable lipid. Additionally, the synthesis of these ionizable lipids involves multiple chemical reactions, often making the process time-consuming and difficult to translate. In this study, we employed a facile, catalyst-free, and versatile one-pot multicomponent reaction (MCR) to develop a library of ionizable lipids featuring a pharmacologically significant tetrahydropyrimidine (THP) backbone, tailored for enhanced mRNA delivery. A library of 26 THP ionizable lipids was systematically synthesized in just 3 h and formulated with luciferase mRNA for initial in vitro screening. The THP LNPs exhibited tunable particle sizes, favorable ζ-potentials, and high encapsulation efficiencies. Among them, THP1 demonstrated the highest transfection efficiency both in vitro and in vivo after intramuscular administration, comparable to DLin-MC3-DMA (MC3), a conventional benchmark. Further optimization of THP1 with phospholipids significantly enhanced intramuscular mRNA delivery and showed sustained protein expression in vivo for up to 5 days. More importantly, it demonstrated successful intravenous delivery in a dose-dependent manner with minimal toxicity, as indicated by hematological, histopathological, and proinflammatory cytokine assessments. Furthermore, THP1 LNPs also demonstrated the ability to edit genes in specific liver tissues in a tdTomato transgenic mouse model, highlighting their precision and utility in targeted therapeutic applications. These findings position THP1 LNPs as promising candidates for advancing mRNA-based therapies, with significant implications for clinical translation in vaccine delivery and CRISPR/Cas9-mediated gene editing in the liver.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, University of Nevada, Las Vegas, Las Vegas, Nevada 89154, United States.
- Nevada Institute of Personalized Medicine, University of Nevada, Las Vegas, Las Vegas, Nevada 89154, United States.
- School of Life Sciences, College of Sciences, University of Nevada, Las Vegas, Las Vegas, Nevada 89154, United States.
- Department of Mechanical Engineering, University of Nevada, Las Vegas, Las Vegas, Nevada 89154, United States.
- Interdisciplinary Biomedical Engineering Program, University of Nevada, Las Vegas, Las Vegas, Nevada 89154, United States.
ORCID-Profile: Ivan Isaac, Chandrabali Bhattacharya
Förderung
- NIA NIH HHS
- NIGMS NIH HHS
- University of Nevada, Las Vegas
- National Institute on Aging
- Pharmaceutical Research and Manufacturers of America Foundation
- National Institute of General Medical Sciences
Zitieren
APA
Isaac, I., Shaikh, A., Bhatia, M., Liu, Q., Park, S., & Bhattacharya, C. (2024). Tetrahydropyrimidine Ionizable Lipids for Efficient mRNA Delivery. ACS Nano, 18(42), 29045-29058. https://doi.org/10.1021/acsnano.4c10154
Vancouver
Isaac I, Shaikh A, Bhatia M, Liu Q, Park S, Bhattacharya C. Tetrahydropyrimidine Ionizable Lipids for Efficient mRNA Delivery. ACS Nano. 2024;18(42):29045-29058. doi:10.1021/acsnano.4c10154
BibTeX
@article{Isaac2024,
author = {Isaac, Ivan and Shaikh, Altab and Bhatia, Mayurakkhi and Liu, Qian and Park, Seungman and Bhattacharya, Chandrabali},
title = {Tetrahydropyrimidine Ionizable Lipids for Efficient mRNA Delivery},
journal = {ACS Nano},
year = {2024},
volume = {18},
number = {42},
pages = {29045--29058},
doi = {10.1021/acsnano.4c10154}
}
EUVIMED